TMSI: a novel, AI-driven alternative microbiological method for microorganism detection, enumeration and identification

, , , , , , , , , and 2026-03-24T14:16:00

shutterstock_1245937975

Spore.Bio illustrates an AI-native, rapid microbiological method (RMM) that offers simultaneous viable quantitation and microbial identification capabilities suited to a range of applications including bioburden tests and environmental monitoring.

Today’s rapid method technologies have numerous capabilities. They can detect the presence of diverse types of microorganisms or a specific microbial species, enumerate the number of microorganisms present in a sample, or identify microbial cultures to the genus, species and sub-species level. However, to our knowledge, there does not exist a rapid technology that provides simultaneous detection, enumeration and microbial identification, without pre-enrichment, viability staining or additional workflow steps. Until now.

Already a member? Sign-in

Unlock

Driving innovation in pharma manufacturing

European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.

Become a member to continue reading

By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:

  • Unlimited access to industry intelligence that can make a difference to your business
  • A weekly newsletter keeping the most vital information at the front of your thinking
  • Exclusive invitations to powerful webinars and events featuring high profile experts
  • Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation

Become a member